Moreover, our analysis revealed that SOCS2 levels are significantly increased in patients with acute and chronic myeloid leukemia, two hematological malignancies where disease progression is closely linked to IL-1β. Here, IL1B is linked to chronic myelogenous leukemia, BCR-ABL1 positive.